The vials labeled “COVID-19 Coronavirus Vaccine” and the syringe are seen in front of the Johnson & Johnson logo displayed in this illustration, February 9, 2021.
Dat Ruvic | Reuters
Johnson & Johnson will reduce deliveries of its single-dose Covid-19 vaccine by 86% next week next week, while facing manufacturing problems at a major plant in Baltimore.
The government allocated only 700,000 J&J wildfires to states next week, down from 4.9 million the previous week, according to the Centers for Disease Control and Prevention.
J&J is awaiting regulatory approval for a facility in Baltimore, which is operated by Emergent BioSolutions Inc. and is working with the US Food and Drug Administration to obtain the authorization.
Workers at the Baltimore plant a few weeks ago mixed ingredients for the J&J and AstraZeneca vaccines, resulting in about 15 million doses of destroyed J&J. The Biden administration put J&J in charge of making the vaccine at the plant and stopped the production of the AstraZeneca vaccine there.
Once authorized, J&J could deliver up to eight million doses each week, Covid-19 White House coordinator Jeff Zients said at a news briefing Friday. And the company is on track to deliver 100 million doses by the end of May.
Michigan Governor Gretchen Whitmer has called on the Biden administration to create vaccines in her state, which is facing the worst outbreak in the country. Michigan expects to receive 17,500 doses of J&J next week, a 88% drop from the previous week.
The administration has said it will continue to allocate photos to the population and does not intend to increase doses to affected states as it cannot predict where infections could continue to grow.
“There are tens of millions of people across the country in every state and county who have not yet been vaccinated,” Zients said Friday. “And the fair and equitable way the vaccine is distributed is based on the adult population across states, tribes and territories. That’s how it was done and we will continue to do so.”
“The virus is unpredictable. We do not know where the next increase in cases could occur,” he added.
New York State Governor Andrew Cuomo said in a statement Friday that the state will receive only 34,900 doses, a 88 percent drop from the previous week.
“As has been the case since the beginning of our vaccination effort, the X factor is supply, supply, supply and, like any other state, Johnson & Johnson’s dose allocation will be significantly lower next week,” Cuomo said.
California will see its J&J allocation drop from 572,700 to 67,600; Florida from 313,200 to 37,000; and Texas from 392,100 to 46,300.
Some states have temporarily stopped vaccination against J&J at certain facilities after people have had side effects. The Georgia Department of Public Health discontinued all photos in one place after eight people experienced reactions, and other sites in North Carolina and Colorado stopped taking doses because of the reactions.
However, the CDC said it found no safety concerns or concerns about J&J doses, according to a statement from the North Carolina Department of Health and Human Services. The Colorado Department of Public Health and the Environment also said “there is no cause for concern.”
“After analyzing each patient’s symptoms, analyzing other vaccinations in the same vaccine batch, and discussing with the CDC to confirm our findings, we are confident that there are no concerns,” said Dr. Eric France, chief medical officer. of the department. officer, said in a statement.
The J&J vaccine was the third vaccine authorized in the United States after the Pfizer and Moderna vaccines. As of Friday night, the company has delivered nearly 15 million doses to the United States, according to CDC data.
The United States administers a seven-day average of 3 million doses of vaccine each day. One in five Americans is now fully vaccinated, according to the CDC.
The rate of new Covid cases and deaths in the United States has dropped dramatically since the beginning of winter, when hundreds of thousands of new infections and thousands of deaths were reported daily.
The seven-day average of new cases in the US was 67,000 on Saturday, according to data from Johns Hopkins University. This is comparable to the growth that swept the nation last summer. The United States reports an average of 982 daily deaths.
New infections are on the rise in 23 states as the most infectious variant first identified in the UK has become the dominant strain in the US President Joe Biden has called on states to open vaccination schedules for all adults by April 19 as the nation fights to immunize as many people as possible as much as possible the virus moves.